3D Printing Speeds Up Manufacturing of CAR T Cells Against Cancer

A new 3D printing technique allows the creation of structures that mimic lymph nodes. In these biological scaffolds, CAR T cells are produced, achieving faster reprogramming and in greater quantity. This reduces manufacturing costs and times, bringing an expensive therapy closer to more patients.

Microscopic view of a 3D bioprinter nozzle depositing hydrogel scaffold material layer by layer, forming a lattice structure mimicking lymph node tissue, while glowing CAR T cells proliferate rapidly inside the porous matrix, robotic arm precisely moving during fabrication, photorealistic medical engineering visualization, translucent biomaterial with embedded fluorescent cell clusters, cool blue ambient lighting with warm orange cell highlights, ultra-detailed microscopic textures, clean lab environment reflection on sterile surfaces

Printed scaffolds replicate the natural environment of lymphocytes 🧬

Researchers designed porous microstructures that mimic the architecture of lymph nodes. By seeding T cells and the necessary genetic material, the 3D environment optimizes cell signaling, allowing cells to reprogram in less than 24 hours. The traditional process requires days and multiple steps. With this technique, higher cell yields are obtained with fewer resources, which lowers production costs.

The plastic lymph nodes that don't need an appointment ☕

It seems lymph nodes already have a low-cost substitute. Now, instead of waiting weeks for a treatment that costs an arm and a leg, we could have CAR T cells manufactured in a printed scaffold. Next up, these artificial lymph nodes will also order coffee to liven up the wait. Meanwhile, cancer trembles and patients' pockets breathe a sigh of relief.